Literature DB >> 26720160

Parsing Pathologic Complete Response in Patients Receiving Neoadjuvant Chemotherapy for Breast Cancer.

Monica Morrow1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26720160     DOI： 10.1001/jamaoncol.2015.4919

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  4 in total

1.  Does neoadjuvant chemotherapy affect morbidity, mortality, reoperations, or readmissions in patients undergoing lumpectomy or mastectomy for breast cancer?

Authors:  Jeffrey Landercasper; Barbara Bennie; Mallory S Bray; Choua A Vang; Jared H Linebarger
Journal:  Gland Surg       Date:  2017-02

2.  Selecting Node-Positive Patients for Axillary Downstaging with Neoadjuvant Chemotherapy.

Authors:  Giacomo Montagna; Anita Mamtani; Andrea Knezevic; Edi Brogi; Andrea V Barrio; Monica Morrow
Journal:  Ann Surg Oncol       Date:  2020-06-02       Impact factor: 5.344

3.  SIAH and EGFR, Two RAS Pathway Biomarkers, are Highly Prognostic in Locally Advanced and Metastatic Breast Cancer.

Authors:  Lauren L Siewertsz van Reesema; Vasilena Zheleva; Janet S Winston; Rick J Jansen; Carolyn F O'Connor; Andrew J Isbell; Minglei Bian; Rui Qin; Patricia T Bassett; Virginia J Hinson; Kimberly A Dorsch; Brad W Kirby; Robert E Van Sciver; Angela M Tang-Tan; Elizabeth A Harden; David Z Chang; Cynthia A Allen; Roger R Perry; Richard A Hoefer; Amy H Tang
Journal:  EBioMedicine       Date:  2016-08-14       Impact factor: 8.143

Review 4.  Predictive and Prognostic Roles of Pathological Indicators for Patients with Breast Cancer on Neoadjuvant Chemotherapy.

Authors:  Xinyan Li; Mozhi Wang; Mengshen Wang; Xueting Yu; Jingyi Guo; Tie Sun; Litong Yao; Qiang Zhang; Yingying Xu
Journal:  J Breast Cancer       Date:  2019-11-04       Impact factor: 3.588
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.